Oral anti-inflammatory action of NPC 18884, a novel bradykinin B 2 receptor antagonist

By Saleh T.S.F.   Vianna R.M.J.   Creczynski-Pasa T.B.   Chakravarty S.   Mavunkel B.J.   Kyle D.J.   Calixto J.B.  

European Journal of Pharmacology, Vol. 363, Iss. 2, 1998-12 ,pp. : 179-187

Elsevier

Access to resources Recommend Favorite

Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B 2 receptor antagonist, FR167344

By Inamura N.   Asano M.   Hatori C.   Sawai H.   Jiro Hirosumi   Fujiwara T.   Kayakiri H.   Satoh S.   Abe Y.   Inoue T.   Sawada Y.   Oku T.   Nakahara K.  

European Journal of Pharmacology, Vol. 333, Iss. 1, 1997-08 ,pp. : 79-86

Elsevier

Access to resources Recommend Favorite

Icatibant, the bradykinin B2 receptor antagonist with target to the interconnected kinin systems

By Charignon Delphine   Späth Peter   Martin Ludovic   Drouet Christian  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 15, 2012-10 ,pp. : 2233-2247

Informa Healthcare

Access to resources Recommend Favorite

Effect of the bradykinin B 2 receptor antagonist Hoe140 in experimental pneumococcal meningitis in the rat

By Lorenzl S.   Kodel U.   Frei K.   Pfister H.-W.  

European Journal of Pharmacology, Vol. 308, Iss. 3, 1996-07 ,pp. : 335-341

Elsevier

Access to resources Recommend Favorite

Effect of FK3657, a non-peptide bradykinin B 2 receptor antagonist, on allergic airway disease models

By Hirayama Y.   Miyayasu K.   Yamagami K.   Imai T.   Ohkubo Y.   Mutoh S.  

European Journal of Pharmacology, Vol. 467, Iss. 1, 2003-04 ,pp. : 197-203

Elsevier

Access to resources Recommend Favorite